Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001484284 | SCV001688700 | likely benign | Hypertrophic cardiomyopathy | 2023-12-12 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001484284 | SCV004824147 | likely benign | Hypertrophic cardiomyopathy | 2024-07-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004994145 | SCV005519954 | likely benign | Cardiovascular phenotype | 2024-09-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |